跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
SOLIFENACINA/TAMSULOSINA CINFAMED 6 MG/0.4 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG
Approved
STANDARD
SOLIFENACINA/TAMSULOSINA CINFAMED 6 MG/0.4 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG
Laboratorios Cinfa S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jan 13, 2023
Approval ID
11b562beaed9be8c
Company
Laboratorios Cinfa S.A.
Type
Standard
Approval Details
Approval Id
11b562beaed9be8c
Drug Cima Aemps Name
SOLIFENACINA/TAMSULOSINA CINFAMED 6 MG/0.4 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG
Register Number
88509
Holder Company Name
Laboratorios Cinfa S.A.
Marketing Company Name
Laboratorios Cinfa S.A.
Authorization Date
2023-01-13
Dosage Form
COMPRIMIDO DE LIBERACIÓN MODIFICADA
Dose
6/0,4 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Laboratorios Cinfa S.A.
Active Ingredients
SOLIFENACINA SUCCINATO
6 mg
TAMSULOSINA HIDROCLORURO
0,40 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jan 13, 2023
Approval ID
11b562beaed9be8c
Type
Standard
Back to CIMA-AEMPS Approvals
SOLIFENACINA/TAMSULOSINA CINFAMED 6 MG/0.4 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG - CIMA-AEMPS Drug Approval Details